Scharf Investments, LLC Cortexyme, Inc. Transaction History

Scharf Investments, LLC

  • $2.96 Billion
  • Q4 2024

A detailed history of Scharf Investments, LLC transactions in Cortexyme, Inc. stock. As of the latest transaction made, Scharf Investments, LLC holds 91,061 shares of CRTX stock, worth $117,468. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91,061
Holding current value
$117,468
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025
BUY
N/A
91,061 New
91,061 $117,000
Q4 2023

Jan 12, 2024
BUY
N/A
91,061 New
91,061 $117,000

Others Institutions Holding CRTX

# of Institutions
40
Shares Held
5.27M
Call Options Held
90.8K
Put Options Held
0
View Full List

About Cortexyme, Inc.

CRTX Quotes by TradingView
  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Scharf Investments, LLC Portfolio

Follow Scharf Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scharf Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scharf Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email